General Statement of Disclosure:

SPEAKER'S BUREAU: Astellas Pharma US(MODEST), Alnylam(MODEST) RESEARCH/RESEARCH GRANTS: Philips(SIGNIFICANT), Myocardial Solutions(SIGNIFICANT), General Electric(SIGNIFICANT), Astellas Pharma(SIGNIFICANT)

View Full Disclosure